The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Disulfiram is a DNA demethylating agent and inhibits prostate cancer cell growth
Open accessAbstract
BACKGROUND: The clinical success of the nucleoside analogs 5‐aza‐cytidine (5‐azaC) and 5‐aza‐2′deoxycytidine (5‐aza‐dC) as DNA methyltransferase (DNMT) inhibitors has spurred interest in the development of non‐nucleoside inhibitors with improved pharmacologic and safety profiles. Because DNMT catalysis features attack of cytosine bases by an enzyme thiol group, we tested whether disulfiram (DSF), a thiol‐reactive compound with known clinical safety, demonstrated DNMT inhibitory activity. METHODS: Inhibition of DNMT1 activity by DSF was assessed using methyltransferase activity assays with recombinant DNMT1. Next, prostate cancer cell lines were exposed to DSF and assessed for: i) reduction of global 5‐methyl cytosine (5me C) content using liquid chromatography/tandem mass spectrometry (LC‐MS/MS); ii) gene‐specific promoter demethylation by methylation‐specific PCR (MSP); and iii) gene‐reactivation by real‐time RT‐PCR. DSF was also tested for growth inhibition using prostate cancer cell lines propagated in vitro in cell culture and in vivo as xenografts in nude mice. RESULTS: Disulfiram showed a dose‐dependent inhibition of DNMT1 activity on a hemimethylated DNA substrate. In prostate cancer cells in culture, DSF exposure led to reduction of global genomic 5me C content, increase in unmethylated APC and RARB gene promoters, and associated re‐expression of these genes, but did not significantly alter prostate‐specific antigen (PSA) expression. DSF significantly inhibited growth and clonogenic survival of prostate cancer cell lines in culture and showed a trend for reduced growth of prostate cancer xenografts. CONCLUSIONS: Disulfiram is a non‐nucleoside DNMT1 inhibitor that can reduce global 5me C content, reactivate epigenetically silenced genes, and significantly inhibit growth in prostate cancer cell lines. Prostate 77:333–343, 2011. © 2010 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Frommer, M., McDonald, L. E., Millar, D. S., Collis, C. M., Watt, F., Grigg, G. W., Molloy, P. L., & Paul, C. L. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.5.1827 · Cited by 3,238
Epigenetics in human disease and prospects for epigenetic therapy
Egger, G., Liang, G., Aparicio, A., & Jones, P. A. (2004) · Nature · doi:10.1038/nature02625 · Cited by 3,232
On the mechanism of inhibition of DNA-cytosine methyltransferases by cytosine analogs
Santi, D. V., Garrett, C. E., & Barr, P. J. (1983) · Cell · doi:10.1016/0092-8674(83)90327-6 · Cited by 401
Cited by
Koppaka, V., Thompson, D. C., Chen, Y., Ellermann, M., Nicolaou, K. C., Juvonen, R. O., Petersen, D., Deitrich, R. A., Hurley, T. D., & Vasiliou, V. (2012) · Pharmacological Reviews · doi:10.1124/pr.111.005538 · Cited by 557
Recent Advances in Drug Repositioning for the Discovery of New Anticancer Drugs
Shim, J. S., & Liu, J. O. (2014) · International Journal of Biological Sciences · doi:10.7150/ijbs.9224 · Cited by 382
Self-citationRen, X., Li, Y., Zhou, Y., Hu, W., Yang, C., Jing, Q., Zhou, C., Wang, X., Hu, J., Wang, L., et al. (2021) · Redox Biology · doi:10.1016/j.redox.2021.102122 · Cited by 313
Cancer Chemoprevention and Nutri-Epigenetics: State of the Art and Future Challenges
Gerhauser, C. (2012) · Topics in Current Chemistry · doi:10.1007/128_2012_360 · Cited by 194
Tang, C., Pang, X., Guo, Z., Guo, R., Liu, L., & Chen, X. (2021) · Drug Metabolism and Disposition · doi:10.1124/dmd.120.000317 · Cited by 14
Metadata
- Authors
- Lin, J., Haffner, M. C., Zhang, Y., Lee, B. H., Brennen, W. N., Britton, J., Kachhap, S. K., Shim, J. S., Liu, J. O., Nelson, W. G., Yegnasubramanian, S., & Carducci, M. A.
- Venue
- The Prostate
- Publisher
- Wiley
- Published
- 2010-08-31
- Volume
- 71
- Issue
- 4
- Pages
- 333-343
- ISSN
- 0270-4137 (ISSN-L)
- 1097-0045
- OpenAlex
- W2148629267
- Cited by
- 194
- References
- 3
- FWCI
- 4.61
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Disulfiram is a DNA demethylating agent and inhibits prostate cancer cell growth. https://app.cochat.ai/papers/10.1002/pros.21247
- The paper
- Lin, J., Haffner, M. C., Zhang, Y., Lee, B. H., Brennen, W. N., Britton, J., Kachhap, S. K., Shim, J. S., Liu, J. O., Nelson, W. G., Yegnasubramanian, S., & Carducci, M. A. (2011). Disulfiram is a DNA demethylating agent and inhibits prostate cancer cell growth. The Prostate. https://doi.org/10.1002/pros.21247
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.